Elcelyx Therapeutics, Inc. — Form D/A

Elcelyx Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2012-08-13. The offering totals $18.1M, of which $18.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (42)

Showing 25 of 42 people.

NameRoleLocation
Alain D. BaronDirectorSan Diego, CA
Brook E. ByersDirectorSan Diego, CA
Ralph E. ChristoffersenDirectorSan Diego, CA
Jim R. GlasheenDirectorSan Diego, CA
Ginger R. GrahamDirectorSan Diego, CA
Alain D. BaronExecutive OfficerSan Diego, CA
Martin R. BrownExecutive OfficerSan Diego, CA
Brook E. ByersExecutive OfficerSan Diego, CA
Mark R. FinemanExecutive OfficerSan Diego, CA
Mark R. WigginsExecutive OfficerSan Diego, CA
Richard BarryDirectorOklahoma City, OK
Bosun HauDirectorSt. Louis, MO
Alain BaronDirectorSan Diego, CA
Alain BaronExecutive OfficerSan Diego, CA
Martin R BrownExecutive OfficerChambersburg, PA
RICHARD J BARRYDirectorCAMBRIDGE, MA
Ginger GrahamDirectorSan Diego, CA
Jim GlasheenDirectorSan Diego, CA
Mark FinemanExecutive OfficerSan Deigo, CA
Christoffersen RalphDirectorSan Diego, CA
Sandy MahatmeDirectorSan Diego, CA
Liang TsuiDirectorSan Diego, CA
Jay SherwoodExecutive OfficerSan Diego, CA
Ralph E ChristoffersonDirectorSan Diego, CA
Liang R TsuiDirectorSan Diego, CA

Other filings by this issuer (9)

FiledFormOfferingSold
2018-11-07D$1.0M$476K
2015-10-07D$40.2M$20.1M
2015-02-19D$9.0M$5.8M
2014-02-21D/A$24.7M$24.7M
2013-02-26D$20.0M$12.0M
2012-12-20D/A$21.1M$21.1M
2011-05-10D/A$14.1M$14.1M
2011-01-26D$6.1M
2010-03-17D$2.2M$1.2M

More